Search Results Search Sort by RelevanceMost Recent Policy Forum Jul 2019 How Should Unaccompanied Minors in Immigration Detention Be Protected From Coercive Medical Practices? Giselle Malina Safeguards are urgently needed for assessments of what constitutes appropriate care for unaccompanied minors in US detention facilities. AMA J Ethics. 2019;21(7):E603-610. doi: 10.1001/amajethics.2019.603. Case and Commentary Dec 2015 Enrolling Research Participants in Private Practice: Conflicts of Interest, Consistency, Therapeutic Misconception, and Informed Consent Armand H. Matheny Antommaria, MD, PhD and Kristin Stanley Bramlage, MD Advice for enrolling patients in clinical trials. AMA J Ethics. 2015;17(12):1122-1126. doi: 10.1001/journalofethics.2015.17.12.ecas3-1512. Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.
Policy Forum Jul 2019 How Should Unaccompanied Minors in Immigration Detention Be Protected From Coercive Medical Practices? Giselle Malina Safeguards are urgently needed for assessments of what constitutes appropriate care for unaccompanied minors in US detention facilities. AMA J Ethics. 2019;21(7):E603-610. doi: 10.1001/amajethics.2019.603.
Case and Commentary Dec 2015 Enrolling Research Participants in Private Practice: Conflicts of Interest, Consistency, Therapeutic Misconception, and Informed Consent Armand H. Matheny Antommaria, MD, PhD and Kristin Stanley Bramlage, MD Advice for enrolling patients in clinical trials. AMA J Ethics. 2015;17(12):1122-1126. doi: 10.1001/journalofethics.2015.17.12.ecas3-1512.
Case and Commentary Aug 2017 Should Clinicians Medicate against Structural Violence? Potential Iatrogenic Risks and the Need for Social Interventions Lauren E. Hock, MD and Niranjan S. Karnik, MD, PhD Risks of off-label medication to treat aggression should be balanced with consequences of not responding to social factors. AMA J Ethics. 2017;19(8):753-761. doi: 10.1001/journalofethics.2017.19.8.ecas2-1708.